Post navigation
- Mortalità correlata al diabete tipo 2: attenzione anche alle cause oncologiche
- Meta‐analysis of head‐to‐head clinical trials comparing incretin‐based glucose‐lowering medications and basal insulin – an update including recently developed GLP‐1 receptor agonists and the GIP/GLP‐1 receptor co‐agonist tirzepatide


